Fulfilling the potential of gene editing: at the tipping point

CELL AND GENE THERAPY INSIGHTS

October 2023

Fulfilling the potential of gene editing: at the tipping point

Download PDF

Expert Insight

Considerations for development of gene-edited PSC-based therapies

Considerations for development of gene-edited PSC-based therapies

Brent Morse, Amanda Mack

14 November 2023

‘Soft’ genome editing using CRISPR nickases as a potential source of safer cell products

‘Soft’ genome editing using CRISPR nickases as a potential source of safer cell products

Zhen Li, Manuel Goncalves

20 October 2023

Commentary

An update on prime editing: recent advances and applications

An update on prime editing: recent advances and applications

Karl Petri, Julian Grünewald

23 November 2023

Unravelling immunogenicity induced by Cas9 in gene therapy: a comprehensive commentary of current understanding and implications

Unravelling immunogenicity induced by Cas9 in gene therapy: a comprehensive commentary of current understanding and implications

Anna Lina Cavallo

8 November 2023

Interview

Advancing multiplex base editing into the clinic

Advancing multiplex base editing into the clinic

10 November 2023

Exploring the convergence of gene editing and RNAi in iPSC-derived allogeneic cell therapy

Exploring the convergence of gene editing and RNAi in iPSC-derived allogeneic cell therapy

8 November 2023

Developing a multiplex gene editing approach targeting viral infection

Developing a multiplex gene editing approach targeting viral infection

8 November 2023

Bringing the Sleeping Beauty transposon system to the clinic

Bringing the Sleeping Beauty transposon system to the clinic

18 October 2023